Fecal Calprotectin in Cystic Fibrosis

Completed

• Conditions: Cystic Fibrosis

• Registration Number: NCT00863694
• Lead Sponsor: Medical College of Wisconsin

Brief Summary

Elevated fecal calprotectin is a biomarker for intestinal inflammation in cystic fibrosis

Detailed Description

Not available

Study Timeline

• Study Start: 2009-02
• Study First Submitted: 2009-03-16
• Study First Submitted QC: 2009-03-17
• Study First Posted: 2009-03-18
• Primary Completion: 2013-08
• Study Completion: 2013-08
• Status Verified: 2013-12
• Last Update Submitted: 2013-12-12
• Last Update Posted: 2013-12-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 106

Inclusion Criteria

• All patients

Exclusion Criteria

• Informed consent/assent not obtained

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
collection of 150 stool specimens	2 years

Trial Locations

Locations (1)

Children's Hospital of Wisconsin; 🇺🇸 Milwaukee, Wisconsin, United States